# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Edward White reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $45 price tar...
JP Morgan analyst Eric Joseph reiterates TG Therapeutics (NASDAQ:TGTX) with a Overweight and maintains $25 price target.
Ladenburg Thalmann analyst Matthew Kaplan reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $39 price target.
https://sam.gov/opp/5efea17b278941f7ae9ba627116a29be/view
HC Wainwright & Co. analyst Edward White reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $45 price tar...